HbA1c Direct
- UID
- MFG/IVD/2021/000060_822d403e6cd840a0125b8b115e209a1e_32cca0ef7613c1ffd53c714a29d0a1c9
- Device class
- Class B
- Brand name
- a
- License holder
- POCT Services Private Limited
- Approving authority
- North Delhi Division
- Product information
- Q-Line® HbA1c Direct kit is intended for in-vitro quantitative determination of PLATINUM% HbA1c (a) in human whole blood. Percent HbA1c measurements are used for monitoring long term glycemic control in diabetic patients
HbA1c Direct is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2021/000060_822d403e6cd840a0125b8b115e209a1e_32cca0ef7613c1ffd53c714a29d0a1c9. This device is marketed under the brand name a. The license holder is POCT Services Private Limited, and it is classified as Device Class Class B. The approving authority is North Delhi Division.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.